Skip to main content

Störungen des Phosphatstoffwechsels

  • Living reference work entry
  • First Online:
SpringerReference Innere Medizin

Part of the book series: SpringerReference Medizin ((SRM))

  • 211 Accesses

Zusammenfassung

Störungen des Phosphatstoffwechsels treten bei einem übermäßigen renalen Phosphatverlust oder durch eine mangelhafte alimentäre Versorgung mit Phosphat auf. Die hierdurch bedingten Krankheitsbilder sind die phosphopenischen Rachitisformen mit muskuloskelettalen Beschwerden und skelettalen Deformierungen seltener kombiniert mit renalen Funktionsstörungen sowie Nephrokalzinose und Nephrolithiasis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Literatur

  • Beck-Nielsen SS, Brock-Jakobsen B, Gram J, Brixen K, Jensen TK (2009) Incidence and prevalence of nutritional and hereditary rickets in Southern Denmark. Eur J Endocrinol 160:491–497

    Article  CAS  PubMed  Google Scholar 

  • Beck-Nielsen SS, Brusgaard K, Rasmussen LM et al (2010) Phenotype presentation of hypophosphatemic rickets in adults. Calcif Tissue Int 87:108–119

    Article  CAS  PubMed  Google Scholar 

  • Berndt M, Ehrich JH, Lazovic D et al (1996) Clinical course of hypophosphatemic rickets in 23 adults. Clin Nephrol 45:126–155

    Google Scholar 

  • Consortium ADHR (2000) Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23. Nat Genet 26:345–348

    Article  Google Scholar 

  • Frymoyer JW, Hodgkin W (1977) Adult onset vitamin D resistant hypophosphatemic osteomalacia. A possible variant of vitamin D resistant rickets. J Bone Joint Surg Am 59:101–106

    CAS  PubMed  Google Scholar 

  • Glorieux FH, Scriver CR, Reade TM et al (1972) Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia. N Engl J Med 287:481–487

    Article  CAS  PubMed  Google Scholar 

  • Gutierrez OM, Mannstadt M, Isakova T et al (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584–592

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kalantar-Zadeh K, Kuwae N, Regidor D et al (2006) Survival predictability of time varying indicator of bone disease maintenance hemodialysis patients. Kidney Int 70:771–780

    Article  CAS  PubMed  Google Scholar 

  • Kurosu H, Ogawa Y, Miyoshi M et al (2006) Regulation of FGF23 signaling by klotho. J Biol Chem 281:6120–6123

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Leaf DE, Pereira RC, Bazari H (2013) Jüppner oncogenic osteomalacia due to FGF23 expressing colon adenocarcinoma. J Clin Endocrinol Metab 98:887–891

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Liu S, Guo R, Simpson LG et al (2003) Regulation of fibroblast growth factor 23 expression but not degradation by PHEX. Biol Chem 278:37419–37426

    Article  CAS  Google Scholar 

  • Liu S, Tang W, Zhou J et al (2006) FGF23 is a counterregulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17:1305–1315

    Article  CAS  PubMed  Google Scholar 

  • Lorenz-Depiereux B, Bastepe M, Benet-Pages A et al (2006) DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 38:1248–1250

    Article  CAS  PubMed  Google Scholar 

  • Quarles LD (2008) Endocrine functions of bone in mineral metabolism regulation. J Clin Invest 118:3820–3828

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ravid M, Robson M (1976) Proximal myopathy caused by iatrogenic phosphate depletion. JAMA 62:1380–1381

    Article  Google Scholar 

  • Reid IR, Hardy DC, Murphy WA et al (1989) X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults. Medicine 68:336–352

    Article  CAS  PubMed  Google Scholar 

  • Riminucci M, Collins MT, Fedarko NS et al (2003) FGF23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112:683–692

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Shimada T, Mizutani S, Muto T et al (2001) Cloning and characterization of FGF23 as a causatuve factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500–6505

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Takeda E, Yamamoto H, Yamanaka-Okumura H, Taketani Y (2012) Dietary phosphorus in bone health and quality of life. Nutr Rev 70:311–321

    Article  PubMed  Google Scholar 

  • Whyte MP, Schranck FM, Armamento-Villareal R (1996) X-linked hypophosphatemia: a search for gender, race, anticipation, or parent of origin effects on disease expression in children. J Clin Endocrinol Metab 81:4075–4080

    CAS  PubMed  Google Scholar 

  • Wöhrle S, Henninger C, Bony O, Thuery A, Beluch N, Hynes NE, Guagnano V, Sellers WR, Hofmann F, Kneissel M, Porta DG (2013) Pharmacological inhibition of fibroblast growth factor receptor signalling ameliorates FGF23 mediated hypophosphatemic rickets. J Bone Miner Res 28:899–911

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christian Kasperk .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Kasperk, C. (2014). Störungen des Phosphatstoffwechsels. In: Lehnert, H. (eds) SpringerReference Innere Medizin. SpringerReference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54676-1_34-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54676-1_34-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-54676-1

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics